# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-003243
Filing Date
2014-05-14
Accepted
2014-05-14 14:44:25
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0314_dandritbiotech.htm | 10-Q | 722665
2 | LOAN AGREEMENT BY AND BETWEEN DANDRIT DENMARK AND PASECO APS DATED APRIL 29, 201 | f10q0314ex10vi_dandritbio.htm | EX-10.6 | 24569
3 | LETTER OF SUPPORT OF PASECO APS RELATED TO COMMITTED 2M DKK IN ADDITIONAL FINANC | f10q0314ex10vii_dandritbio.htm | EX-10.7 | 4448
4 | CERTIFICATION | f10q0314ex31i_dandritbio.htm | EX-31.1 | 11772
5 | CERTIFICATION | f10q0314ex31ii_dandritbio.htm | EX-31.2 | 11816
6 | CERTIFICATION | f10q0314ex32i_dandritbio.htm | EX-32.1 | 5695
7 | CERTIFICATION | f10q0314ex32ii_dandritbio.htm | EX-32.2 | 5696
| Complete submission text file | 0001213900-14-003243.txt |  | 4617403

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 |  | pmhs-20140331.xml | EX-101.INS | 581813
9 |  | pmhs-20140331.xsd | EX-101.SCH | 43637
10 |  | pmhs-20140331_cal.xml | EX-101.CAL | 54277
11 |  | pmhs-20140331_def.xml | EX-101.DEF | 89337
12 |  | pmhs-20140331_lab.xml | EX-101.LAB | 341157
13 |  | pmhs-20140331_pre.xml | EX-101.PRE | 227470

Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54478 | Film No.: 14840867
SIC: 2834 Pharmaceutical Preparations